MiNK Therapeutics, Inc.
INKT· Nasdaq
MiNK Therapeutics, Inc.
- Last sale
- Oct 1, 2026 · +1.83%
- Market cap
- $65.47M
- 5.1M shares
- Filings
- 263
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $5,757,487 | reported | |
| FY 2024 | 2024-12-31 | $6,336,075 | reported | |
| FY 2023 | 2023-12-31 | $15,489,997 | reported | |
| FY 2022 | 2022-12-31 | $23,115,123 | reported | |
| FY 2021 | 2021-12-31 | $13,966,368 | reported | |
| FY 2020 | 2020-12-31 | $9,509,055 | reported |
MiNK Therapeutics, Inc. · CIK 1840229 · Engraved from SEC EDGAR
